Come & Quit: A new flexible, Intensive Smoking Cessation Intervention Programme

Mette Rasmussen 1,2 Marianne Kaas 3, Sine Maria Helldén 3, Niels Them Kjaer 3, Hanne Tønnesen 1,2

About the author: 

1 Clinical Health Promotion Centre, WHO-CC, Parker Institute, Bispebjerg-Frederiksberg, Hospital, Denmark
2 Clinical Health Promotion Centre, WHO-CC, Region Skåne and Dept of Health Science, Lund University,weden
3 Danish Cancer Society, Copenhagen, Denmark

Abstract
Aim Smoking cessation is a major challenge for many smokers, and it is necessary to develop and evaluate new programmes. The aim was to compare the effectiveness of ‘Come & Quit’, a flexible, intensive smoking cessation intervention (SCI) with the Danish gold standard programme (GSP). Second, we aimed to identify whether gender was important among disadvantaged
and heavy smokers.

Methods This was a prospective cohort study based on the Danish National Smoking Cessation Database. From 2011-2016, we included 24,930 smokers from smoking cessation units throughout Denmark; 5,750 received ‘Come & Quit’, and 19,180 received the GSP.
Results A total of 16,348 respondents were included in the outcome analyses on continuous abstinence after six months. Thirty-five percent remained successful quitters. Under the Russell criterion, the crude quit rate was 23.0%. The most important predictor was compliance. Overall, men had 3.0-3.1% higher quit rates than women for both programmes. The fully adjusted model confirmed the significantly higher success among men (OR=1.15, 95% CI: 1.07-1.23). Two multivariable logistic
regression analyses for men and women showed no statistically significant differences between ‘Come & Quit’ and the GSP for men (OR=1.06, 0.92-1.23) or women (OR=0.94, 0.82-1.08). Across gender, compliance with the programmes was the most important predictor of successful quitting. Minor predictors were calendar year, lack of social disadvantage and heavy smoking.

Conclusion The effectiveness of the intensive interventions compared in this study was similar across genders. However, overall, men had a significantly higher quit rate than women.

doi.org/10.29102/clinhp.19004

Introduction

Smoking is a major risk factor for the glo­bal disease burden. Approximately 80% of all smoking takes place in low- and middle-income countries, but smoking is still the leading risk factor in high-in­come countries. Worldwide, smoking kil­led 7.10 million persons in 2017 and was responsible for 182 million disability-ad­justed life years (DALYs), understood as the number of years of healthy life lost (1).

 

Smoking cessation is on the agenda wor­ldwide, and many actions are taken to reduce the smoking rate at national and local levels, aiming at preventing new smokers from starting and supporting smokers to quit – as recommended by the Framework Convention of Tobacco Control from the World Health Orga­nization (2). Nevertheless, successfully quitting is still a major challenge for many smokers. Therefore, it is necessary to develop and evaluate new programmes to ensure success in quitting. Today, in­tensive smoking cessation intervention (SCI) programmes are recommended for vulnerable groups and hospital patients or is simply the standard programme for the general public (3).

 

Intensive SCI is defined by having at least four structured face-to-face meetings la­sting more than 10 minutes per session and including elements of patient educa­tion (4). It is recommended but not man­datory to include pharmaceutical support (4). Many programmes contain a patient education part, relapse prevention and follow-up, which is also the case for the national gold standard programme (GSP) in Denmark (5-8) (table 1).

 

We have previous­ly shown that women and smokers with high or medi­um-high levels of were overrepresented in the Danish SCI (9).

 

Some groups of smokers may not have the opportunity to take part in a programme with a fixed time schedule such as the GSP but could benefit from a more flexible intervention allowing participation when it fits into the smokers’ life conditions in combination with adjusted content and increased support between meetings. The intention was also to attract groups of smokers other than those using the GSP to participate in SCI, especial­ly men and smokers with little or no education. Thus, a more flexible but still intensive SCI called ‘Come & Quit’ was developed (10) (table 1).

 

 

 

 

 

The aim of this study was to compare the effectiveness of the new flexible ‘Come & Quit’ programme and the GSP in Denmark, measured as successful quitting after 6 months. Second, we wanted to investigate whether gender influenced the outcome among disadvantaged or heavy smokers among the users of the two program­mes.

 

Methods

Participants

A total of 24,930 smokers participated in this study: 5,750 received ‘Come & Quit’, and 19,180 received the GSP. They originated from 136 SCI units throughout Denmark offering intensive face-to-face SCI in the period from January 2011 to December 2016, with a 6-month follow up through May 2017.

 

The inclusion criterion was being a smoker with com­pleted or attempted follow-up after 6 months in the study period (n=33,487). The exclusion criteria were being smokers who did not want to be followed up (n=763), those below 15 years of age (n=39) and those not receiving the GSP or Come & Quit (n=7,755).

 

Data collection

The SCI units reported their activities in the national Danish Smoking Cessation Database. The database was established in 2001 with the purpose of monitoring, evaluating and improving the quality of face-to-face SCI in Denmark. To date, more than 130.000 smokers undertaking an SCI have been registered in the databa­se after providing informed consent. The Smoking Ces­sation Database has been described in detail elsewhere (8).

The data reported in the SCDB used in this study in­cluded an individual smoking history and socio-demo­graphic profile of each smoker as well as a description of the programme delivered and the smoking status at the 6-month follow-up (see table 2) (8).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Education was categorized into three levels: no educa­tion or short courses, less than three years of education, and three or more years of education. Compliance was measured as meeting attendance, and a smoker was defined as being compliant with the programme when participating in at least 75% of the planned sessions in the GSP (11) and at least four sessions in the ‘Come & Quit’ programme (8). Disadvantaged smokers were de­fined as having no education or short courses only and/ or as having no employment (12). Heavy smokers were defined by at least one of the following characteristics: ≥20 pack years, ≥20 gram of tobacco per day and/or ≥7 points for the Fagerström score of nicotine dependency (13).

 

Interventions

The Gold Standard Program (GSP) (5-8) has been recommended as the standard intervention in Den­mark since 1995 (14), and it includes 5 sessions over six weeks. A few participants attended extra meetings. The programme was manual based and was based on motivational counselling, individualised pharmaceuti­cal support and structured patient education to increa­se the individual health literacy regarding smoking, cessation and strategies for handling situations with relapse risk. Homework between sessions supported smoking cessation. The large majority of the GSP took place in groups, but an individual GSP was also possi­ble (details in table 1). The Smoking Cessation Data­base began registration for the GSP in 2001 when the database was established (8).

 

’Come & Quit’ (8;10) was developed later, aiming to be a more flexible programme to attract more smokers with little or no education and more male smokers. All smokers began with an individual counselling session. Despite the intensive intervention structure and phar­macological support, the programme was very flexible and took place in running groups where each smoker had the opportunity to jump in and out of eight dif­ferent manual-based sessions on eight themes. This intervention aimed to increase the support between meetings by offering text messages, e-mails or phone calls. In addition, the quit date was made flexible to adapt to the individual needs of the participants, and the educational material that was developed contained only small amounts of text. Furthermore, each meeting was shortened (1.5 hours compared to 2 hours in the GSP). The Smoking Cessation Database began registra­tion for ‘Come & Quit’ in 2011.

 

Statistics

The two programmes were compared by means of chi2 tests regarding participant characteristics. The quit rates were compared using a mixed-effect regression model by adjusting for selected predictors and hierar­chical clustering. The final model was fitted based on initial logistic regressions adjusting for sex and age and based on established knowledge. These results were described as odds ratios (ORs) with 95% confidence intervals (CIs). The details of the analyses have been described previously (9). A result was considered stati­stically significant if the p-value was ≤ 0.05.

 

Results

The characteristics of all 24,930 included smokers are presented in table 2. The large majority of smokers participated in the GSP (19,180; 76.9%), whereas 5,750 (23.1%) undertook the ‘Come & Quit’ programme.

Most of the participants in the GSP completed 4 and 5 meetings (corresponding to a meeting adherence abo­ve 75%) and experienced high quit-rates. The ‘Come & Quit’ was characterised by a more spread out meeting adherence. This group showed an increasing quit-rate closely related to number of meetings (figure 2 + 3).

The successful follow-up rate was 66% (trial profile in figure 1). The proportion of smokers not wanting the follow-up was slightly higher in the ‘Come & Quit’ pro­gramme than in the GSP (2.8% versus 2.4%, respecti­vely, p = 0.04). There was no difference regarding the other exclusion criteria.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Most of the participants in the GSP completed 4 or 5 meetings (corresponding to a meeting adherence rate above 75%) and experienced high quit rates. ‘Come & Quit’ was characterised by a wider range of meeting adherence. This group showed an increasing quit rate closely related to the number of meetings attended (fi­gure 2 and 3).

 

 

 

 

 

 

 

 

 

Successful quitting rates are presented in table 3 as crude rates according to the programme, sex, level of education and calendar year at the onset of the inter­vention. Overall, 35.0% (5,752) of the 16,348 respon­dents included in the outcome analyses reported con­tinuously being successful in smoking cessation after six months. When considering the 8,400 non-respon­dents as smokers, the crude quit rate was 23.0% (table 3). Men had a higher quit rate than women for both programmes: 3.0% and 3,1% higher in the base case for ‘Come & Quit’ and the GSP, respectively. The fully ad­justed model confirmed a significantly higher quit rate among men (OR=1.15, 95% CI: 1.07-1.23; p<0.001).

 

 

 

 

 

 

 

 

 

Furthermore, from the gender perspective for ‘Come & Quit’ and GSP, the two separate multivariable logistic regression analyses for men and women, respectively, showed no statistically significant differences between the programmes, either for men (OR=1.06, 0.92-1.23) or for women (OR=0.94, 0.82-1.08); see table 4. For both men and women, being compliant with the pro­gramme was the most important predictor of succes­sful quitting. Other minor predictors across genders were calendar year, lack of social disadvantage or heavy smoking (table 4).

Analysis of non-responders

The analysis of non-respondents compared with re­spondents showed no differences regarding SCI pro­gramme, amount of tobacco per day or format (group or individual counselling). All other factors, including age, employment, social disadvantage, pack year and living condition, differed up to 5 percentage points, ex­cept for compliance with the programme, which diffe­red by 14.5 percentage points.

 

Overall, the non-respondents tended to be individuals from a more disadvantaged group.

 

Discussion

This study showed that both ‘Come & Quit’ and GSP were followed by similarly high quit rates of 35% after 6 months among those followed up or 23% if the third group not responding to follow-up were considered to be still smoking. Overall, men had a significantly hig­her quit rate than women. The most important predic­tor was the compliance measure of attendance.

 

Overall, the intensive SCI is more effective than shor­ter interventions (4) and represents the standard for SCIs in Denmark (5-8). The proportion of successful quitting found in this study is similar to that in pre­vious studies on the effect of a GSP (11-13;17;18) but high compared to that in other studies of intensive SCIs (19-24). The difference may be due to differences in the programme details but also to the settings, the smokers included and the use of validation as described below.

 

It is important to evaluate new intensive interventions such as ´Come & Quit’, as they are generally recom­mended for vulnerable and disadvantaged groups (3).

 

‘Come & Quit’ has involved considerations related to health literacy. On a practical and individual-oriented level, ‘Come & Quit’ heeds the call of international po­licies, such as the World Health Organization’s (WHO) 2016 Shanghai Declaration, concerning the improve­ment of health literacy (25) of people – namely, the knowledge and skills needed to make healthy choices in life (26). Health literacy is defined as the skills, know­ledge and confidence that determine the motivation and ability of individuals to gain access to, understand and use information in ways that promote and main­tain good health, such as by quitting smoking (25;27). On the level of individual/groups, such health promo­tion actions that include elements of education, coun­selling, support and empowerment in terms of health literacy can contribute considerably to population he­alth as valuable complimentary strategies to the more structural health promotion actions and strategies such as governance-level initiatives. Interestingly, this was not reflected in the results, as both programmes attrac­ted similar groups of smokers.

 

From the clinical perspective, health care professionals need to become familiar with the new ‘Come & Quit’ programme to be able to offer it to smokers. From the smokers’ perspective, it is beneficial to have more intensive programmes with a similarly large effect to choose between, as preferences may differ from one smoker to another. At the healthcare and societal level, the results support the recommendation for using an intensive SCI. An existing challenge to be addressed in further research is that even though ‘Come & Quit’ was developed to attract smokers with little or no education and male smokers, no difference was observed regar­ding these characteristics.

 

Bias and limitations

The increasing use of ‘Come & Quit’ over the study period could introduce a bias from a learning curve, where peop­le show increasingly better outcomes over time. The fol­low-up interviews were performed by the Danish Quit-li­ne but not validated otherwise by, e.g., CO or nicotine measurement. The lack of validation may have resulted in over-estimating the quit rate. Another bias originates from the one-third of individuals not responding to follow-up. They were considered to be still smoking, but the quit rate may differ between individuals in the two programmes and among the individual smokers. The non-respondent analysis is, however, a strength of this study. The study also has limitations, as the intervention tool was situated in a Danish context with a widespread cluster of SCI units all over the country, and the results may therefore not be transferable to other settings.

 

Conclusion

In conclusion, the two intensive interventions ‘Come & Quit‘ and the Danish GSP were both effective with similar quit rates of 35%; however, in both programmes, men had a higher quit rate than women, though the difference was small. The most important predictor was the compliance measure of attendance.

 

Acknowledgements

Thank you to the Ministry of Health, the Danish National Board of Health, the Bispebjerg & Frederiksberg Hospital, and the Danish Cancer Society for financing the smoking cessation database.

Also, thank you very much to all the smokers who have agreed to provide information about their smoking cessa­tion programmes and outcomes in the Smoking Cessation Database, as well as to the staff at the smoking cessation units.

 

All authors participated in the development of the re­search project. Mette Rasmussen performed the analyses. All authors took part in the interpretation. Hanne Tønne­sen wrote the manuscript. All authors edited and appro­ved the final version.

 

References

(1) GBD 2017 Risk Factor Collaborators. Global, regional, and national com­parative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990- 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392: 1923-94. Doi: 10.1016/S0140-6736(18)32225-6.

(2) World Health Organization. Framework Convention on Tobacco Control. WHO Document Production Services, Geneva, Switzerland 2003. ISBN 978 92 4 159101 0

(3) NICE National Institute for Health and Care Excellence. Public health guideline: Smoking: acute, maternity and mental health services (PH48). NICE. Available from: https://www.nice.org.uk/guidance/ph48/chapter/1-Re­commendations#recommendation-3-provide-intensive-support-for-peop­le-using-acute-and-mental-health-services

(4) Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons and SA Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update. Am J Prev Med 2008;35:158–76. Avai­lable from: http://www.ncbi.nlm.nih.gov/pubmed/18617085

(5) Kaas M, Helldén SM. Manual for individual smoking cessation. 6th edition. Danish Cancer Society; 2018. Available from: https://www.rsiden.dk/materia­ler/rygestop-individuelt/

(6) Lind M, Jaspers K, Kjaer NT. Smoking Cessation - Theory and Practice of Professional Counsellors. Danish Cancer Society; 2009. Available from: www. cancer.dk

(7) Kaas M, Helldén SM. Manual for smoking cessation in groups, 4th edition. Danish Cancer Society; 2016. Available from: https://www.rsiden.dk/materia­ler/rygestop-i-grupper/

(8) Rasmussen M, Tønnesen H. The Danish Smoking Cessation Database. Clin Heal Promot 2016;6(2):36–41. Doi: 10.29102/ clinhp.16006

(9) Rasmussen M, Fernández E, Tønnesen H. Effectiveness of the Gold Stan­dard Programme compared with other smoking cessation interventions in Denmark: a cohort study. BMJ Open 2017 Feb 27;7(2):e013553. Doi: 10.1136/ bmjopen-2016-013553

(10) Nielsen LM. Manual for Come & Quit, 3rd edition. Danish Cancer Society; 2015. Available from: https://www.rsiden.dk/materialer/kom-og-kvit/manua­ler-og-markedsfoering/

(11) Ghith N, Ammari ABH, Rasmussen M, Frølich A, Cooper K, Tønnesen H. Impact of compliance on quit rates in a smoking cessation intervention: population study in Denmark. Clin Heal Promot. 2012;2(3):111–9. Available from: http://www.clinhp.org

(12) Neumann T, Rasmussen M, Ghith N, Heitmann BL, Tønnesen H. The Gold Standard Programme: smoking cessation interventions for disadvantaged smokers are effective in a real-life setting. Tob Control [Internet]. 2013;22(e9). Doi: 10.1136/tobaccocontrol-2011-050194.

(13) Neumann T, Rasmussen M, Heitmann BL, Tønnesen H. Gold Standard Program for Heavy Smokers in a Real-Life Setting. Int J Environ Res Public Health 2013;10:4186–99. Doi: 10.3390/ijerph10094186

(14) Lind M, Jaspers K. Manual for individual smoking cessation. 5th edition. Danish Cancer Society; 2011.

(15) Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The Reporting of studies Conducted using Observational Routinely collec­ted health Data (RECORD) Statement. PLOS Med. 2015;12(10):e1001885. Doi: 10.1371/journal.pmed.1001885.

(16) West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessa­tion trials: proposal for a common standard. Addiction 2005 Mar;100(3):299– 303. Doi: 10.1111/j.1360-0443.2004.00995.x

(17) Rasmussen M, Klinge M, Krogh J, Nordentoft M, Tønnesen H. Effective­ness of the Gold Standard Programme (GSP) for smoking cessation on smo­kers with and without a severe mental disorder: a Danish cohort study. BMJ Open. 2018 Jun 11;8(6):e021114. doi: 10.1136/bmjopen-2017-021114.

(18) Møller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet. 2002 Jan 12;359(9301):114-7.

(19) Nohlert E, Tegelberg Å, Tillgren P, Johansson P, Rosenblad A, Helgason ÁR. Comparison of a high and a low intensity smoking cessation interventi­on in a dentistry setting in Sweden: a randomized trial. BMC Public Health. 2009;9:121. doi:10.1186/1471-2458-9-121.

(20) Romand R, Gourgou S, Sancho-Garnier H. A randomized trial assessing the Five-Day Plan for smoking cessation. Addiction. 2005;100:1546-1554. doi:10.1111/j.1360-0443.2005.01215.x.

(21) Wewers ME, Ferketich AK, Harness J, Paskett ED. Effectiveness of a nurse-managed, lay-led tobacco cessation intervention among ohio appa­lachian women. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3451-3458. doi:10.1158/1055-9965.epi-09-0952.

(22) Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive Smoking Cessation Intervention Reduces Mortality in High- Risk Smokers With Cardiovascular Disease. Chest. 2007;131(2):446-452. doi:10.1378/chest.06-1587.

(23) Baker A, Richmond R, Haile M, et al. A Randomized Controlled Trial of a Smoking Cessation Intervention Among People With a Psychotic Disorder. Am J Psychiatry. 2006;163(11):1934-1942. doi:10.1176/ajp.2006.163.11.1934.

(24) El Hajj M, Kheir N, Al Mulla A, Shami R, Fanous N, Mahfoud Z. Effecti­veness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial. BMC Public Health. 2017;17:215. doi:10.1186/s12889-017-4103-4.

(25) Nutbeam D. The evolving concept of health literacy. Social science & medicine 2008; 67(12): 2072-8. doi: 10.1016/j.socscimed.2008.09.050.

(26) Organization WH. Shanghai Declaration on promoting health in the 2030 Agenda for Sustainable Development. 2016.

(27) Nutbeam D. Health Promotion Glossary. www.who.int/healthpromotion/ about/HPR%20Glossary%201998.pdf: World Health Organization (WHO), 1998.

Contact us
About us

© Clinical Health Promotion 2019